1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical Contract Manufacturing (BCMO) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Mammalian Based Manufacturing
1.2.3 Microbial Based Manufacturing
1.2.4 Other
1.3 Market by Application
1.3.1 Global Biopharmaceutical Contract Manufacturing (BCMO) Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Bio-Pharmaceutical Companies
1.3.3 Pharmaceutical Companies
1.3.4 Drug Discovery Companies
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical Contract Manufacturing (BCMO) Market Perspective (2017-2028)
2.2 Biopharmaceutical Contract Manufacturing (BCMO) Growth Trends by Region
2.2.1 Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biopharmaceutical Contract Manufacturing (BCMO) Historic Market Size by Region (2017-2022)
2.2.3 Biopharmaceutical Contract Manufacturing (BCMO) Forecasted Market Size by Region (2023-2028)
2.3 Biopharmaceutical Contract Manufacturing (BCMO) Market Dynamics
2.3.1 Biopharmaceutical Contract Manufacturing (BCMO) Industry Trends
2.3.2 Biopharmaceutical Contract Manufacturing (BCMO) Market Drivers
2.3.3 Biopharmaceutical Contract Manufacturing (BCMO) Market Challenges
2.3.4 Biopharmaceutical Contract Manufacturing (BCMO) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical Contract Manufacturing (BCMO) Players by Revenue
3.1.1 Global Top Biopharmaceutical Contract Manufacturing (BCMO) Players by Revenue (2017-2022)
3.1.2 Global Biopharmaceutical Contract Manufacturing (BCMO) Revenue Market Share by Players (2017-2022)
3.2 Global Biopharmaceutical Contract Manufacturing (BCMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical Contract Manufacturing (BCMO) Revenue
3.4 Global Biopharmaceutical Contract Manufacturing (BCMO) Market Concentration Ratio
3.4.1 Global Biopharmaceutical Contract Manufacturing (BCMO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Contract Manufacturing (BCMO) Revenue in 2021
3.5 Biopharmaceutical Contract Manufacturing (BCMO) Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical Contract Manufacturing (BCMO) Product Solution and Service
3.7 Date of Enter into Biopharmaceutical Contract Manufacturing (BCMO) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical Contract Manufacturing (BCMO) Breakdown Data by Type
4.1 Global Biopharmaceutical Contract Manufacturing (BCMO) Historic Market Size by Type (2017-2022)
4.2 Global Biopharmaceutical Contract Manufacturing (BCMO) Forecasted Market Size by Type (2023-2028)
5 Biopharmaceutical Contract Manufacturing (BCMO) Breakdown Data by Application
5.1 Global Biopharmaceutical Contract Manufacturing (BCMO) Historic Market Size by Application (2017-2022)
5.2 Global Biopharmaceutical Contract Manufacturing (BCMO) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biopharmaceutical Contract Manufacturing (BCMO) Market Size (2017-2028)
6.2 North America Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2017-2022)
6.3 North America Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Biopharmaceutical Contract Manufacturing (BCMO) Market Size (2017-2028)
7.2 Europe Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2017-2022)
7.3 Europe Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical Contract Manufacturing (BCMO) Market Size (2017-2028)
8.2 Asia-Pacific Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2017-2022)
8.3 Asia-Pacific Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Biopharmaceutical Contract Manufacturing (BCMO) Market Size (2017-2028)
9.2 Latin America Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2017-2022)
9.3 Latin America Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical Contract Manufacturing (BCMO) Market Size (2017-2028)
10.2 Middle East & Africa Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2017-2022)
10.3 Middle East & Africa Biopharmaceutical Contract Manufacturing (BCMO) Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Lonza Group Ltd
11.1.1 Lonza Group Ltd Company Detail
11.1.2 Lonza Group Ltd Business Overview
11.1.3 Lonza Group Ltd Biopharmaceutical Contract Manufacturing (BCMO) Introduction
11.1.4 Lonza Group Ltd Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
11.1.5 Lonza Group Ltd Recent Development
11.2 Boehringher Ingelheim
11.2.1 Boehringher Ingelheim Company Detail
11.2.2 Boehringher Ingelheim Business Overview
11.2.3 Boehringher Ingelheim Biopharmaceutical Contract Manufacturing (BCMO) Introduction
11.2.4 Boehringher Ingelheim Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
11.2.5 Boehringher Ingelheim Recent Development
11.3 Sandoz
11.3.1 Sandoz Company Detail
11.3.2 Sandoz Business Overview
11.3.3 Sandoz Biopharmaceutical Contract Manufacturing (BCMO) Introduction
11.3.4 Sandoz Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
11.3.5 Sandoz Recent Development
11.4 Fujifilm Diosynth Biotechnology
11.4.1 Fujifilm Diosynth Biotechnology Company Detail
11.4.2 Fujifilm Diosynth Biotechnology Business Overview
11.4.3 Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing (BCMO) Introduction
11.4.4 Fujifilm Diosynth Biotechnology Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
11.4.5 Fujifilm Diosynth Biotechnology Recent Development
11.5 Rentschler Biotechnologie
11.5.1 Rentschler Biotechnologie Company Detail
11.5.2 Rentschler Biotechnologie Business Overview
11.5.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing (BCMO) Introduction
11.5.4 Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
11.5.5 Rentschler Biotechnologie Recent Development
11.6 Celonic GmbH
11.6.1 Celonic GmbH Company Detail
11.6.2 Celonic GmbH Business Overview
11.6.3 Celonic GmbH Biopharmaceutical Contract Manufacturing (BCMO) Introduction
11.6.4 Celonic GmbH Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
11.6.5 Celonic GmbH Recent Development
11.7 BIOMEVA GmbH
11.7.1 BIOMEVA GmbH Company Detail
11.7.2 BIOMEVA GmbH Business Overview
11.7.3 BIOMEVA GmbH Biopharmaceutical Contract Manufacturing (BCMO) Introduction
11.7.4 BIOMEVA GmbH Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
11.7.5 BIOMEVA GmbH Recent Development
11.8 ProBioGen AG
11.8.1 ProBioGen AG Company Detail
11.8.2 ProBioGen AG Business Overview
11.8.3 ProBioGen AG Biopharmaceutical Contract Manufacturing (BCMO) Introduction
11.8.4 ProBioGen AG Revenue in Biopharmaceutical Contract Manufacturing (BCMO) Business (2017-2022)
11.8.5 ProBioGen AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
